| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/18/2006 | US20060105344 Modulation of deubiquitinase family members |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105330 Diagnostics and remedies for malignant brain tumor |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/18/2006 | US20060105067 Comprises a flavones extract and polysaccharides |
| 05/18/2006 | US20060105065 Liquid seasoning |
| 05/18/2006 | US20060105064 Composition for treating skin ulcers |
| 05/18/2006 | US20060105063 Synergic combination of compositions containing aloe vera isolates and their therapeutic application |
| 05/18/2006 | US20060105062 Composition and method for modulating addictive behaviors |
| 05/18/2006 | US20060105050 Compositions comprising fenofibrate and simvastatin |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060105046 Polymer conjugates of opioid antagonists |
| 05/18/2006 | US20060105045 Cyclodextrin solubilizers for liquid and semi-solid formulations |
| 05/18/2006 | US20060105042 axon regeneration kits comprising containers containing fibrinogen, thrombin, calcium chloride, poly/ADP-ribose/polymerase and N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboamide and drug delivery devices; kinase inhibitors |
| 05/18/2006 | US20060105041 4-Hydroxy tamoxifen gel formulations |
| 05/18/2006 | US20060105040 Pharmaceutical tablet and process for making thereof |
| 05/18/2006 | US20060105037 Sustained release pharmaceutical preparations and methods for producing the same |
| 05/18/2006 | US20060105034 Formulation and delivery method to enhance antioxidant potency of Vitamin E |
| 05/18/2006 | US20060105033 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 05/18/2006 | US20060105031 Accelerating recovery from trauma |
| 05/18/2006 | US20060105027 Method for treating skin ulcers |
| 05/18/2006 | US20060105023 Treatment of neurological disorders with nicotine |
| 05/18/2006 | US20060105022 Process for preparing crosslinked hyaluronic acid gel |
| 05/18/2006 | US20060105021 Cholesterol-reducing liquid |
| 05/18/2006 | US20060105019 Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
| 05/18/2006 | US20060105006 Use of metalloprotease inhibitors to induce and/or stimulate the growth of head hair or other hairs and/or to slow down their loss |
| 05/18/2006 | US20060104999 Composition for solubilization of paclitaxel and preparation method thereof |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104997 Monoterpene compositions and uses thereof |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104985 Dengue virus infection inhibitor |
| 05/18/2006 | US20060104984 Methods and compositions for use in treating cancer |
| 05/18/2006 | US20060104983 Regions of the protein acting as surface epitopes, capable of providing inhibitors for RLIP76. include antibodies, si- RNA directed against one or more surface epitope regions; screening chemical libraries for compounds that bind ralA binding protein 1 and effect its transport activity |
| 05/18/2006 | US20060104975 C-type lectin binding molecules, identification and uses thereof |
| 05/18/2006 | US20060104965 Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| 05/18/2006 | US20060104956 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer |
| 05/18/2006 | US20060104951 Akt and regulation of RA synovial fibroblast apoptosis |
| 05/18/2006 | US20060104947 Remedy for pemphigoid |
| 05/18/2006 | US20060104946 Method for treating inflammatory bowel disease |
| 05/18/2006 | US20060104944 Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use |
| 05/18/2006 | US20060104942 Anticholesterol agents; anticholesterol agents; cardiovascular disorders; mixture of colony stimulating factor and hepatocyte growth factor |
| 05/18/2006 | US20060104941 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 05/18/2006 | US20060104940 Cosmetic, pharmaceutical and dermatological preparations comprising copolymer waxes |
| 05/18/2006 | US20060104937 for topical application; synergistic combination of zinc pyrithione antidandruff agent and conjugated linoleic acid |
| 05/18/2006 | US20060104917 Stable pharmaceutical products |
| 05/18/2006 | US20060104913 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 05/18/2006 | US20060104912 Mousse composition |
| 05/18/2006 | US20060104909 Abuse-resistant pharmaceutical compositions |
| 05/18/2006 | US20060104902 Method of preselection patients for anti-VEGF, anti-HIF-1 or anti-thioredoxin therapy |
| 05/18/2006 | US20060104901 Preventing or treating epithelial tissue damage or hair loss |
| 05/18/2006 | US20060104897 Method for diagnosing and treating nis-expressing carcinomas and metastases |
| 05/18/2006 | US20060103807 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 05/18/2006 | DE19608751B4 Verwendung eines Adeno-assoziierten Virus-Vektors zur Steigerung der Immunogenität von Zellen Using an adeno-associated virus vector to enhance the immunogenicity of cells |
| 05/18/2006 | DE10349979B4 Medikamentöse gezielte lokale Lipolyse Drug targeted local lipolysis |
| 05/18/2006 | DE102005048695A1 Preparation of aripiprazole useful to prepare 7-(4-halobutoxy)-3,4-dihydro-(1H)-quinolinone comprises reacting 7-hydroxy-3,4-dihydro-2(1H)-quinolinone with 1,4-disubstuted-butane followed by reacting with 1-(2,3-dichlorophenyl)piperazine |
| 05/18/2006 | DE102005048694A1 Preparation of 7-hydroxy-3,4-dihydroquinolinone useful as an intermediate in preparing aripiprazole for treating schizophrenia involves reacting N-(3-methoxyphenyl)-3-chloropropionamide with Lewis acid |
| 05/18/2006 | DE102004055633A1 New 5-substituted quinoline and isoquinoline derivatives are glucocorticoid receptor binders useful for treating inflammatory diseases e.g. alveolitis, Sjogren's syndrome, atopic dermatitis, acute lymphatic leukemia, rhinitis and emesis |
| 05/18/2006 | DE102004055284A1 Pharmaceutical composition containing phospholipid, sterol and negative charge carrier, useful in human or veterinary medicine for treating e.g. arthropod, protozoal and bacterial infections or tumors |
| 05/18/2006 | DE102004054873A1 Behandlung von Mastitis Treatment of mastitis |
| 05/18/2006 | DE102004054634A1 Azaindolcarboxamide Azaindolcarboxamide |
| 05/18/2006 | DE102004054603A1 New D-xylopyranosyl-substituted phenyl compounds are sodium-dependent glucose cotransporter inhibitors useful to prevent or treat e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis |
| 05/18/2006 | DE102004054552A1 Neue Zusammensetzung zur Erleichterung der Humangeburt New composition to facilitate human childbirth |
| 05/18/2006 | DE10156794B4 Arzneimittel zur Behandlung von Warzen Medicines used to treat warts |
| 05/18/2006 | CA2596543A1 Methods of treating hematological malignancies with nucleoside analog drugs |
| 05/18/2006 | CA2591474A1 Therapeutic or preventive agents for ischemic heart disease or ischemic cardiomyopathy |
| 05/18/2006 | CA2588073A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 05/18/2006 | CA2587826A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | CA2587671A1 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2587620A1 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
| 05/18/2006 | CA2587609A1 4-amino-5-oxo-8-phenyl-5h-pyrido[2,3-d]pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 05/18/2006 | CA2587498A1 Novel betulin derivatives, preparation thereof and use thereof |
| 05/18/2006 | CA2587470A1 Combination therapy associating preferably a ceramide with a cytotoxic drug |
| 05/18/2006 | CA2587464A1 Inhibitors of hiv-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof |
| 05/18/2006 | CA2587461A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | CA2587444A1 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | CA2587413A1 Macrolones - amino substituted quinolones |
| 05/18/2006 | CA2587336A1 Ptpase inhibitors and t-cell activators for treating cancer |
| 05/18/2006 | CA2587283A1 S-mirtazapine for the treatment of hot flush |
| 05/18/2006 | CA2587276A1 Nanoparticulate compositions of tubulin inhibitor compounds |
| 05/18/2006 | CA2587192A1 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 05/18/2006 | CA2587173A1 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | CA2587018A1 Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death |
| 05/18/2006 | CA2587013A1 Histone deacetylase inhibitors |
| 05/18/2006 | CA2586987A1 Methods and compositions for treating cellular proliferative diseases |
| 05/18/2006 | CA2586975A1 Method for treatment of movement disorders |
| 05/18/2006 | CA2586968A1 Medical device for delivering biologically active material |
| 05/18/2006 | CA2586950A1 Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| 05/18/2006 | CA2586946A1 Nutrition containing fat blend |
| 05/18/2006 | CA2586929A1 N,n'-diphenylurea derivatives suitable as kinase inhibitors |
| 05/18/2006 | CA2586918A1 Use of ion channel modulating compounds for treating acute atrial fibrillation in a human |
| 05/18/2006 | CA2586870A1 Il-12 modulatory compounds |
| 05/18/2006 | CA2586840A1 Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure |
| 05/18/2006 | CA2586761A1 Methods of treating diabetes mellitus |
| 05/18/2006 | CA2586752A1 Substituted pyrrolidone compounds as ep4 agonists |
| 05/18/2006 | CA2586701A1 Lna oligonucleotides and the treatment of cancer |
| 05/18/2006 | CA2586688A1 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 05/18/2006 | CA2586679A1 Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| 05/18/2006 | CA2586649A1 Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases |
| 05/18/2006 | CA2586623A1 Process for preparing quinoline compounds and products obtained therefrom |